Details for New Drug Application (NDA): 204890
✉ Email this page to a colleague
The generic ingredient in PEMETREXED DISODIUM is pemetrexed disodium. There are twenty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the pemetrexed disodium profile page.
Summary for 204890
Tradename: | PEMETREXED DISODIUM |
Applicant: | Qilu Pharm Hainan |
Ingredient: | pemetrexed disodium |
Patents: | 0 |
Pharmacology for NDA: 204890
Mechanism of Action | Folic Acid Metabolism Inhibitors |
Medical Subject Heading (MeSH) Categories for 204890
Suppliers and Packaging for NDA: 204890
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 204890 | ANDA | Ingenus Pharmaceuticals, LLC | 50742-340 | 50742-340-01 | 1 VIAL in 1 CARTON (50742-340-01) / 4 mL in 1 VIAL |
PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 204890 | ANDA | Ingenus Pharmaceuticals, LLC | 50742-341 | 50742-341-01 | 1 VIAL in 1 CARTON (50742-341-01) / 20 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 100MG BASE/VIAL | ||||
Approval Date: | May 25, 2022 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | May 25, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription